Frank Theobald | Vice President, Head MAP Program
LTS Lohmann Therapie-Systeme AG

Frank Theobald, Vice President, Head MAP Program, LTS Lohmann Therapie-Systeme AG

Frank Theobald drives the strategic evolution of microneedle technology as Corporate Vice President and Head of the MAP Program at LTS. With nearly three decades in formulation development and project leadership, he transforms complex ideas into market‑ready drug‑delivery solutions. Frank shapes LTS’s global MAP strategy, accelerates innovative development pipelines, and forges impactful collaborations with academia and industry. His work positions MAPs as a disruptive technology redefining patient‑centric delivery. Frank graduated from the University of the Saarland in Pharmacy and received his PhD in Pharmaceutical Technology from the same University in 1997.

Appearances:



Pre-Congress Workshops (19th October) @ 14:15

Panel: From Non-Inferiority to Impact: Accelerating Adoption of Needle-Free Vaccine Delivery

Session led by: Daicel Life Sciences
last published: 19/Aug/26 15:45 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2026

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com


Stan Dooley

Stan.Dooley@terrapinn.com

 

TO SPEAK


Isla Sutherland

Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com